ESMO: Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes

ESMO Clinical Practice Guidelines for cancer prevention and screening
  

Navigate This Article

1. Top
2. prevalence and epidemiology
3. initial counselling and follow-up of BRCA mutation carriers
4. breast cancer risk reduction
5. ovarian cancer risk reduction
6. screening recommendations following risk-reducing surgery
7. screening recommendations following a diagnosis of breast and ovarian cancer
8. reproductive considerations in BRCA mutation carriers
9. prevention and screening of other BRCA-associated cancers and approach to male carriers
10. prevention and screening of cancer in the presence of other moderate- to high-risk genetic mutation syndromes
11. personalised medicine and future directions
12. methodology
13. conflict of interest
14. references